1887

Chapter 14 : Signal Amplification Methods

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Signal Amplification Methods, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch14-1.gif /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch14-2.gif

Abstract:

Signal amplification methods were initially designed as an alternative to the target amplification technologies such as polymerase chain reaction (PCR) so as to minimize the possibility of contamination by target amplification products. Unlike target amplification, signal amplification methods (as defined herein) do not rely on enzymes for the amplification. Probe-based amplification techniques such as cleavage-based amplification (36) and rolling-circle amplification (1) rely on enzymes, and will not be covered in this chapter. Signal amplification increases or amplifies the signal generated from the probe molecule hybridized to the target nucleic acid sequence. The advantages of signal amplification methods include specific detection, dynamic range, ease-of-use, and reproducibility. To date these methods have met the challenge from advanced or automated target amplification methods such as real time PCR. Signal amplification technologies include hybrid capture (HC) and branched DNA (bDNA) assays (32, 33). The HC method was developed and marketed initially by Digene Corporation (Gaithersburg, MD) which was acquired by Qiagen (Valencia, CA) in 2007. The bDNA method was initially developed by Chiron (Emeryville, CA), marketed by Bayer Diagnostics (Emeryville, CA) which diagnostic division was acquired by Siemens (Tarrytown, NY) in 2006. Due to the growing demand for quick time to detection, automation, and multiplexing, the popularity of commercial signal amplification methods has declined in clinical virology laboratories.

Citation: Wang Y. 2016. Signal Amplification Methods, p 167-172. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch14
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Scheme for Hybrid Capture 2 (HC2) technology.

Citation: Wang Y. 2016. Signal Amplification Methods, p 167-172. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Scheme for branched DNA (bDNA) technology.

Citation: Wang Y. 2016. Signal Amplification Methods, p 167-172. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819156.ch14
1. Ali MM, Li F, Zhang Z, Zhang K, Kang DK, Ankrum JA, Le XC, Zhao W. 2014. Rolling circle amplification: a versatile tool for chemical biology, materials science and medicine. Chem Soc Rev 43:33243341.[PubMed]
2. Arbyn M, Snijders PJ, Meijer CJ, Berkhof J, Cuschieri K, Kocjan BJ, Poljak M. 2015. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect 21:817826.[PubMed]
3. Baumeister MA, Zhang N, Beas H, Brooks JR, Canchola JA, Cosenza C, Kleshik F, Rampersad V, Surtihadi J, Battersby TR. 2012. A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround. PLoS One 7:e33295.[PubMed]
4. Beck S, Köster H. 1990. Applications of dioxetane chemiluminescent probes to molecular biology. Anal Chem 62:22582270.[PubMed]
5. Beld M, Sentjens R, Rebers S, Weegink C, Weel J, Sol C, Boom R. 2002. Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay. J Clin Microbiol 40:788793.[PubMed]
6. Binnicker MJ, Pritt BS, Duresko BJ, Espy MJ, Grys TE, Zarka MA, Kerr SE, Henry MR. 2014. Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results. J Clin Microbiol 52:37633768.[PubMed]
7. Cao Y, Ho DD, Todd J, Kokka R, Urdea M, Lifson JD, Piatak M Jr, Chen S, Hahn BH, Saag MS, Shaw GM. 1995. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses 11:353361.[PubMed]
8. Church D, Gregson D, Lloyd T, Klein M, Beckthold B, Laupland K, Gill MJ. 2011. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections. J Clin Microbiol 49:118124.[PubMed]
9. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, Gabriel R, Quereux C, Birembaut P. 1999. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 80:13061311.[PubMed]
10. Clavel C, Masure M, Putaud I, Thomas K, Bory JP, Gabriel R, Quereux C, Birembaut P. 1998. Hybrid Capture II, a new sensitive test for human papillomavirus detection. Comparison with Hybrid Capture I and PCR results in cervical lesions. J Clin Pathol 51:737740.[PubMed]
11. Collins ML, Irvine B, Tyner D, Fine E, Zayati C, Chang C, Horn T, Ahle D, Detmer J, Shen LP, Kolberg J, Bushnell S, Urdea MS, Ho DD. 1997. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res 25:29792984.[PubMed]
12. Elbeik T, Charlebois E, Nassos P, Kahn J, Hecht FM, Yajko D, Ng V, Hadley K. 2000. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5. J Clin Microbiol 38:11131120.[PubMed]
13. Elbeik T, Alvord WG, Trichavaroj R, de Souza M, Dewar R, Brown A, Chernoff D, Michael NL, Nassos P, Hadley K, Ng VL. 2002. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5. J Acquir Immune Defic Syndr 29:330339.[PubMed]
14. Elbeik T, Surtihadi J, Destree M, Gorlin J, Holodniy M, Jortani SA, Kuramoto K, Ng V, Valdes R Jr, Valsamakis A, Terrault NA. 2004. Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA). J Clin Microbiol 42:563569.[PubMed]
15. Germer JJ, Heimgartner PJ, Ilstrup DM, Harmsen WS, Jenkins GD, Patel R. 2002. Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 assays for quantification of hepatitis C virus RNA in serum. J Clin Microbiol 40:495500.[PubMed]
16. Gianotti N, Galli L, Racca S, Salpietro S, Cossarini F, Spagnuolo V, Barda B, Canducci F, Clementi M, Lazzarin A, Castagna A. 2012. Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL. J Antimicrob Chemother 67:213217.[PubMed]
17. Horn T, Urdea MS. 1989. Forks and combs and DNA: the synthesis of branched oligodeoxyribonucleotides. Nucleic Acids Res 17:69596967.[PubMed]
18. Kern D, Collins M, Fultz T, Detmer J, Hamren S, Peterkin JJ, Sheridan P, Urdea M, White R, Yeghiazarian T, Todd J. 1996. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 34:31963202.[PubMed]
19. Kulmala SM, Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Podistov J, Ivanchenko O, Zakharenko S, Nerovjna R, Kljukina L, Branovskaja M, Grunberga V, Juschenko A, Tosi P, Santopietro R, Syrjänen K. 2004. Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol 42:24702475.[PubMed]
20. Laudadio J. 2013. Human papillomavirus detection: testing methodologies and their clinical utility in cervical cancer screening. Adv Anat Pathol 20:158167.[PubMed]
21. Lorincz A, Anthony J. 2001. Hybrid capture method of detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep. 12:145154.
22. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA. 1999. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281:16051610.[PubMed]
23. Mazzulli T, Drew LW, Yen-Lieberman B, Jekic-McMullen D, Kohn DJ, Isada C, Moussa G, Chua R, Walmsley S. 1999. Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia. J Clin Microbiol 37:958963.[PubMed]
24. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJInternational Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Human papillomavirus and cancer: the epidemiological evidence. N Engl J Med 348:518527.[PubMed]
25. Pachl C, Todd JA, Kern DG, Sheridan PJ, Fong S-J, Stempien M, Hoo B, Besemer D, Yeghiazarian T, Irvine B, Kolberg J, Kokka R, Neuwald P, Urdea MS. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol 8:446454.[PubMed]
26. Peyton CL, Schiffman M, Lörincz AT, Hunt WC, Mielzynska I, Bratti C, Eaton S, Hildesheim A, Morera LA, Rodriguez AC, Herrero R, Sherman ME, Wheeler CM. 1998. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 36:32483254.[PubMed]
27. Phillips S, Garland SM, Tan JH, Quinn MA, Tabrizi SN. 2015. Comparison of the Roche Cobas 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for detection of high-risk human papillomavirus genotypes in women undergoing treatment for cervical dysplasia. J Clin Virol 62:6365.
28. Sollis KA, Smit PW, Fiscus S, Ford N, Vitoria M, Essajee S, Barnett D, Cheng B, Crowe SM, Denny T, Landay A, Stevens W, Habiyambere V, Perrins J, Peeling RW. 2014. Systematic review of the performance of HIV viral load technologies on plasma samples. PLoS One 9:e85869.[PubMed]
29. Solomon D, Schiffman M, Tarone R ALTS Study Group. 2001. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 93:293299.[PubMed]
30. Tipple C, Oomeer S, Dosekun O, Mackie N. 2014. Service impact of a change in HIV-1 viral load quantification assay. J Int AIDS Soc 17(Suppl 3):19677.[PubMed]
31. Veillon P, Payan C, Picchio G, Maniez-Montreuil M, Guntz P, Lunel F. 2003. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy. J Clin Microbiol 41:32123220.[PubMed]
32. Wang YF,. 2006. Signal amplification techniques, p 228–242. In Tang Y.-W., and Stratton C.W. (ed), Advanced Techniques in Diagnostic Microbiology. Springer, New York, NY.
33. Wang YF, Eaton ME, Schuetz AN, Nesheim SR,. 2008. Human Immunodeficiency Virus, p 47–67. In Hayden RT, Carroll K, Tang YW, Wolk DM (ed), Diagnostic Microbiology of the Immunocompromised Host. ASM Press, Washington, DC.
34. Wong AA, Fuller J, Pabbaraju K, Wong S, Zahariadis G. 2012. Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium. J Clin Microbiol 50:2529.[PubMed]
35. Yu S, Kwon MJ, Lee EH, Park H, Woo HY. 2015. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus. J Med Virol 87:15871593.[PubMed]
36. Zhao Y, Zhou L, Tang Z. 2013. Cleavage-based signal amplification of RNA. Nat Commun 4:1493.[PubMed]

Tables

Generic image for table
TABLE 1

Comparison of bDNA and HC2 technologies

Citation: Wang Y. 2016. Signal Amplification Methods, p 167-172. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch14

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error